Rehabilitation / Clinical research
NOCI is proud to have collaborative relationships with Key Opinion Leaders in the clinical and research realms.
We are able to execute assigned scope of work and help clients maintain HIPAA & FDA compliance.
Providing an opportunity for integration, convergence, and collaboration across borders by respecting and conserving the richness of diversity.
Leading the future of improved delivery and management of healthcare to affect a positive change in neurological, musculoskeletal and oncological science.
Neural Outcomes Consulting Inc. is proud to share Daiichi Sankyo’s latest announcement regarding approval of their FDA New Drug Application for the drug Turalio, the approved drug is a result of the Enliven study. NOCI was happy to assist in this pivotal trial in providing support for elements of protocol development, ROM outcome measure design, education and training, components of data analysis and KOL guidance for the FDA-NDA submission. NOCI takes great pride in providing support to pharmaceutical companies that develop life changing treatments for rare diseases. Congratulations to Daiichi Sankyo-Enliven Study on this new achievement.
For more information on the new drug now branded as TURALIO™, please click here.
Leading From Humanity
This conference is dedicated to gaining a deeper understanding of what relationship centered care means for healthcare. NOCI CSO, Dr. Sukhvinder Kalsi-Ryan will be speaking with neuro patient and friend, Jeff Edelist, on how they bring humanity to other patients. Register and learn more about this conference here.
What is one thing that is becoming a rare commodity in health care? On June 6, 2019 NOCI CEO, Dr. Kalsi-Ryan will be speaking at the ALIVE in Healthcare Conference on the importance of humanity in health care and what role she is playing in its ongoing development of patient centered care excellence. To learn more click here
Toronto Rehab Lyndhurst Centre’s Rocket North Clinic enhances access to innovative therapies and it’s clinical research is helping to restore function in people with spinal cord injuries.
Neural Outcomes Consulting Inc, CEO and Chief Scientific Officer, Dr. Kalsi Ryan takes on the workshop, Conservative Care for Spine Conditions: Defining the Gap and Finding Rehabilitation Solutions, at the 8th annual Global Spine Congress taking place May 15-18, 2019 in Toronto, Ont. Alongside Darryl Yardley, Angelo Papachristos, Laura Passalent, Julie Vaughan-Grant, Carole Chebarro, Dr. Kalsi- Ryan’s goal is to build a foundation for inter-professional necessity between surgeons and physical therapists. To learn more please visit https://www.gsc2019.org/.
Sunnybrook-Toronto Rehab Visiting Professorship
On Thursday, May 30th, 2019, Dr. Kalsi-Ryan co-hosts the Visiting Professorship at the TRI Lyndhurst Centre. Co-hosting with Sunnybrook Hospital, TRI welcomes a very informative visit from University of Miami’s Chair of Neurosurgery, Dr. Allan D. Levi, who will be speaking on “novel treatment strategies for spinal cord and periphery nerve injury”. Read more here.
Dr. Kalsi-Ryan, CSO, NOCI has great success in Nottwil, Switzerland at the Tetrahand World Congress 2018. Working with rehabilitation leaders, Dr. Kalsi-Ryan participated in a workshop aimed to develop a consensus on the assessment in tetra hand surgery. The workshop leads will be releasing a consensus in the coming months. Visit www.tetrahand2018.com/ for more information.
Grasp and Release Test Launch
Neural Outcomes Consulting Inc. has launched the newly developed Grasp and Release Test at the Tetrahand World Congress 2018 in Nottwil, Switzerland. NOCI partnered with the Cleveland FES Center to make the GRT readily available to the rehab community. The GRT was to help shape the use of standardized outcomes in tetra hand surgery and will be available on our eCommerce platform in the coming months.
Sponsor of NeuroTrauma 2018
As a proud sponsor, we are pleased to announce that NeuroTrauma 2018 was a great success! Professor Armin Curt, Dr. Andrew Maas, Dr. Nicole von Steinbruches, and our CSO, Dr. Sukhvinder Kalis-Ryan delivered an excellent update on outcomes in TBI and SCI. The well-attended session fostered a lively and much-needed discussion on the state of outcomes in Neurotrauma. Visit www.neurotrauma2018.com/ for more info.